Davis Glenn Eugene 4
4 · ISTA PHARMACEUTICALS INC · Filed Mar 5, 2012
Insider Transaction Report
Form 4
Davis Glenn Eugene
VP Legal & Chief Comp. Officer
Transactions
- Disposition to Issuer
COMMON STOCK
2012-03-01$8.23/sh−1,222$10,057→ 27,983 total
Footnotes (1)
- [F1]1-25% of the original award vested. A portion of the vested shares were traded to cover income taxes.